Fierce Biotec

• Biotec

Fierce Biotech is your source for the latest news, analysis and data in the world of biotech and pharma R&D.

• Gura's weekly amylin obesity asset well-tolerated, tied to weight loss in phase 1 trial

• Adaptimmune gears up for another FDA submission after hitting goal in pivotal sarcoma study

• Fierce Biotech Fundraising Tracker '24: TRexBio roars with $84M series B; Metsera brings in hefty $215M raise

• It’s all about the Journey: Entero inks reverse merger with ADC rival biotech

• Syros flunks phase 3 blood cancer trial, triggering loan default and share-price plunge